CytomX Therapeutics Announces Third Quarter 2018 Financial Results

Go back to CytomX Therapeutics Announces Third Quarter 2018 Financial Results
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.27 -0.08 (2.39%)
Previous Close $3.35    52 Week High $24.68 
Open $3.38    52 Week Low $9.10 
Day High $3.41    P/E N/A 
Day Low $3.23    EPS $0.00 
Volume 992,590